Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

Regulatory authorities emphasize integrated control strategies, but CAR-T specification setting requires balancing data rigor with regulatory flexibility.

In the race of evolution, innovating is certainly necessary, but recycling existing genes is sometimes more efficient. Indeed, organisms that are very distant from each other can exchange a ...

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

UF scientists are developing high‑tech, gene‑edited citrus varieties to help Florida growers fight citrus greening and speed ...

Two variants in a single gene are implicated in almost all Alzheimer’s and nearly half of all dementia cases, according to new findings.

A novel CRISPR defense mechanism, unlike known nucleases, specifically destroys transfer ribonucleic acids (tRNA) that are ...

Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of ExcellenceBOSTON & MILAN--(BUSINESS WIRE)- ...

Aseptic processing demands reliable, robust, and validated analytical methods to ensure sterility, safety, and quality, ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Red Rock Technology and City Meta Lab have announced a strategic collaboration aimed at redefining how food security, ...

Remitly, a trusted provider of digital financial services that transcends borders and the Philippines' leading licensed ...